 Connection
Toby Trujillo to Humans
This is a "connection" page, showing publications Toby Trujillo has written about Humans.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.372 |
|
|
|
-
Dixon DL, Jurga T, Kelly M, Landup D, Lu Y, Macaulay T, Munger M, Norgard N, Rogers KC, Trujillo T. Key Articles and Guidelines in the Management of Chronic Coronary Disease. J Pharm Pract. 2026 Jun; 39(3):145-164.
Score: 0.023
-
Dobesh PP, Trujillo TC. Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2024 02; 72(2):631-633.
Score: 0.020
-
Dobesh PP, Trujillo TC. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19. Pharmacotherapy. 2020 11; 40(11):1130-1151.
Score: 0.016
-
Dobesh PP, Finks SW, Trujillo TC. Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events. Clin Ther. 2020 10; 42(10):2084-2097.
Score: 0.016
-
Powell M, Tremolet de Villers K, Schwarz K, Case D, Trujillo T. A Single-Center Retrospective Evaluation of the Use of Oral Factor Xa Inhibitors in Patients With Cerebral Venous Thrombosis. Ann Pharmacother. 2021 03; 55(3):286-293.
Score: 0.016
-
Dietrich SK, Mixon M, Holowatyj M, Werth JC, Delgado SA, Mascolo NE, Meister ER, Zoucha SM, Trujillo TC. Multi-centered evaluation of a novel fixed-dose four-factor prothrombin complex concentrate protocol for warfarin reversal. Am J Emerg Med. 2020 10; 38(10):2096-2100.
Score: 0.016
-
Trujillo TC, Dobesh PP, Crossley GH, Finks SW. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation. Pharmacotherapy. 2019 01; 39(1):94-108.
Score: 0.014
-
Trujillo JM, McNair CD, Linnebur SA, Valdez C, Trujillo TC. The Impact of a Standalone, Patient-centered Communication Course Series on Student Achievement, Preparedness, and Attitudes. Am J Pharm Educ. 2016 Dec 25; 80(10):174.
Score: 0.012
-
Trujillo T, Dobesh PP. Clinical use of rivaroxaban: pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications. Drugs. 2014 Sep; 74(14):1587-603.
Score: 0.011
-
Knapp KK, Mészáros K, Goldsmith PC, McCarter GC, Hester EK, McBane SE, Bottorff MB, Carnes TA, Dell K, Gonyeau MJ, Greco AJ, McConnell KJ, Skaar DJ, Splinter MY, Trujillo TC. Alternative viewpoint: preparation for residency. Pharmacotherapy. 2014 Aug; 34(8):e157-8.
Score: 0.011
-
Babilonia KM, Golightly LK, Gutman JA, Hassell KL, Kaiser JN, Kiser TH, Klem PM, Trujillo TC. Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization. Clin Appl Thromb Hemost. 2014 Nov; 20(8):799-806.
Score: 0.011
-
Hester EK, McBane SE, Bottorff MB, Carnes TA, Dell K, Gonyeau MJ, Greco AJ, McConnell KJ, Skaar DJ, Splinter MY, Trujillo TC. Educational outcomes necessary to enter pharmacy residency training. Pharmacotherapy. 2014; 34(4):e22-5.
Score: 0.010
-
Burnett AE, Trujillo TC. The future of inpatient anticoagulation management. J Thromb Thrombolysis. 2013 Apr; 35(3):375-86.
Score: 0.010
-
Dobesh PP, Beavers CJ, Herring HR, Spinler SA, Stacy ZA, Trujillo TC. Key articles and guidelines in the management of acute coronary syndrome and in percutaneous coronary intervention: 2012 update. Pharmacotherapy. 2012 Dec; 32(12):e348-86.
Score: 0.009
-
Finks SW, Airee A, Chow SL, Macaulay TE, Moranville MP, Rogers KC, Trujillo TC. Key articles of dietary interventions that influence cardiovascular mortality. Pharmacotherapy. 2012 Apr; 32(4):e54-87.
Score: 0.009
-
Dobesh PP, Trujillo TC. Anticoagulation in the management of ST-segment elevation myocardial infarction. J Pharm Pract. 2010 Aug; 23(4):335-43.
Score: 0.008
-
Trujillo TC. Emerging anticoagulants for venous thromboembolism prevention. Am J Health Syst Pharm. 2010 May 15; 67(10 Suppl 6):S17-25.
Score: 0.008
-
Haines ST, Dager WE, Trujillo TC. Clinical and management challenges in preventing venous thromboembolism in health systems: a case-based panel discussion. Am J Health Syst Pharm. 2010 May 15; 67(10 Suppl 6):S26-30.
Score: 0.008
-
Dobesh PP, Trujillo TC. Anticoagulation in the management of non-ST-segment elevation acute coronary syndrome. J Pharm Pract. 2010 Aug; 23(4):324-34.
Score: 0.008
-
Dobesh PP, Trujillo TC. Ranolazine: a new option in the management of chronic stable angina. Pharmacotherapy. 2007 Dec; 27(12):1659-76.
Score: 0.007
-
Trujillo TC, Dobesh PP. Traditional management of chronic stable angina. Pharmacotherapy. 2007 Dec; 27(12):1677-92.
Score: 0.007
-
Trujillo TC. Advances in the management of stable angina. J Manag Care Pharm. 2006 Oct; 12(8 Suppl):S10-6.
Score: 0.006
-
Stacy ZA, Dobesh PP, Trujillo TC. Cardiovascular risks of cyclooxygenase inhibition. Pharmacotherapy. 2006 Jul; 26(7):919-38.
Score: 0.006
-
Itkin YM, Trujillo TC. Intravenous immunoglobulin-associated acute renal failure: case series and literature review. Pharmacotherapy. 2005 Jun; 25(6):886-92.
Score: 0.006
-
Blotske K, Patel T, Trujillo T, Marlar M, Lind S, Kramer H, Hassell K, Kiser TH. Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients. Clin Appl Thromb Hemost. 2025 Jan-Dec; 31:10760296251319961.
Score: 0.005
-
Dager WE, Trujillo TC, Gilbert BW. Approaches to Precision-based Anticoagulation management in the critically Ill. Pharmacotherapy. 2023 11; 43(11):1221-1236.
Score: 0.005
-
Nay I, Hutchinson D, Rondina M, Kim K, Kroencke R, Kirkham A, Trujillo T, Tolley ND, Munger M. Prospective, randomized, controlled, trial to assess ASA DOSing by body mass index in HEalthy volunteers (DOSE study). Pharmacotherapy. 2023 03; 43(3):215-225.
Score: 0.005
-
Novak AR, Shakowski C, Trujillo TC, Wright GC, Mueller SW, Kiser TH. Evaluation of safety and efficacy outcomes of direct oral anticoagulants versus warfarin in normal and extreme body weights for the treatment of atrial fibrillation or venous thromboembolism. J Thromb Thrombolysis. 2022 Aug; 54(2):276-286.
Score: 0.005
-
Courtney LA, Trujillo TC, Saseen JJ, Wright G, Palkimas S. Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge. Ann Pharmacother. 2022 09; 56(9):981-987.
Score: 0.004
-
Jenrette J, Schwarz K, Trujillo T, Ray L. Evaluation of direct oral anticoagulant use on thromboelastography in an emergency department population. Am J Emerg Med. 2022 Feb; 52:191-195.
Score: 0.004
-
Williams B, Saseen JJ, Trujillo T, Palkimas S. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome. J Thromb Thrombolysis. 2022 Jul; 54(1):67-73.
Score: 0.004
-
Beavers CJ, DiDomenico RJ, Dunn SP, Cox J, To L, Weeks P, Trujillo TC, Jennings DL. Optimizing anticoagulation for patients receiving Impella support. Pharmacotherapy. 2021 11; 41(11):932-942.
Score: 0.004
-
Farrar JE, Trujillo TC, Mueller SW, Beltran L, Nguyen C, Hassell K, Kiser TH. Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19. J Thromb Thrombolysis. 2022 Feb; 53(2):446-453.
Score: 0.004
-
Stevens VM, Trujillo TC, Kiser TH, MacLaren R, Reynolds PM, Mueller SW. Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:10760296211039020.
Score: 0.004
-
Trujillo TC, Nolan PE. Antiarrhythmic agents: drug interactions of clinical significance. Drug Saf. 2000 Dec; 23(6):509-32.
Score: 0.004
-
Furnish C, Wagner S, Dangler A, Schwarz K, Trujillo T, Stolpman N, May S. Evaluation of Medication Administration Timing-Are We Meeting Our Goals? J Pharm Pract. 2021 Oct; 34(5):750-754.
Score: 0.004
-
Beyer JT, Lind SE, Fisher S, Trujillo TC, Wempe MF, Kiser TH. Evaluation of intravenous direct thrombin inhibitor monitoring tests: Correlation with plasma concentrations and clinical outcomes in hospitalized patients. J Thromb Thrombolysis. 2020 Feb; 49(2):259-267.
Score: 0.004
-
Dobesh PP, Bhatt SH, Trujillo TC, Glaubius K. Antidotes for reversal of direct oral anticoagulants. Pharmacol Ther. 2019 12; 204:107405.
Score: 0.004
-
Stevens VM, Trujillo T, Mueller SW, MacLaren R, Reynolds PM, Kiser TH. Coagulation Factor Xa (Recombinant), Inactivated-Zhzo (Andexanet Alfa) Hemostatic Outcomes and Thrombotic Event Incidence at an Academic Medical Center. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619896619.
Score: 0.004
-
Trujillo TC, Nolan PE. Unfractionated heparin in acute coronary syndromes: has its time come and gone? Am J Health Syst Pharm. 1998 Nov 15; 55(22):2402-9.
Score: 0.004
-
Finks SW, Dobesh PP, Trujillo TC, Crossley GH. Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures. Cardiol Rev. 2018 Sep/Oct; 26(5):245-254.
Score: 0.003
-
Smythe MA, Trujillo T, Fanikos J. Reversal agents for use with direct and indirect anticoagulants. Am J Health Syst Pharm. 2016 May 15; 73(10 Suppl 2):S27-48.
Score: 0.003
-
Finks SW, Trujillo TC, Dobesh PP. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy. Ann Pharmacother. 2016 06; 50(6):486-501.
Score: 0.003
-
Beyer J, Trujillo T, Fisher S, Ko A, Lind SE, Kiser TH. Evaluation of a Heparin-Calibrated Antifactor Xa Assay for Measuring the Anticoagulant Effect of Oral Direct Xa Inhibitors. Clin Appl Thromb Hemost. 2016 Jul; 22(5):423-8.
Score: 0.003
-
Anderson M, Hassell KL, Trujillo TC, Wolfe B. When patients on target-specific oral anticoagulants need surgery. Cleve Clin J Med. 2014 Oct; 81(10):629-39.
Score: 0.003
-
Lind SE, Boyle ME, Fisher S, Ishimoto J, Trujillo TC, Kiser TH. Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples. Am J Clin Pathol. 2014 May; 141(5):665-74.
Score: 0.003
-
Misky GJ, Carlson T, Thompson E, Trujillo T, Nordenholz K. Implementation of an acute venous thromboembolism clinical pathway reduces healthcare utilization and mitigates health disparities. J Hosp Med. 2014 Jul; 9(7):430-5.
Score: 0.003
-
Miller MP, Trujillo TC, Nordenholz KE. Practical considerations in emergency management of bleeding in the setting of target-specific oral anticoagulants. Am J Emerg Med. 2014 Apr; 32(4):375-82.
Score: 0.003
-
Dobesh PP, Trujillo TC, Finks SW. Role of the pharmacist in achieving performance measures to improve the prevention and treatment of venous thromboembolism. Pharmacotherapy. 2013 Jun; 33(6):650-64.
Score: 0.002
-
Misky GJ, Manheim JC, Zehnder N, Nguyen V, Swenson PF, Klem P, Trujillo T, Earnest MA. Health care disparities in the acute management of venous thromboembolism based on insurance status in the U.S. J Thromb Thrombolysis. 2011 Nov; 32(4):393-8.
Score: 0.002
-
Kiser TH, Mann AM, Trujillo TC, Hassell KL. Evaluation of empiric versus nomogram-based direct thrombin inhibitor management in patients with suspected heparin-induced thrombocytopenia. Am J Hematol. 2011 Mar; 86(3):267-72.
Score: 0.002
-
Chow SL, Dorsch MP, Dunn SP, Jackevicius CA, Page RL, Trujillo T, Vardeny O, Wiggins B, Bleske BE. Key articles related to complementary and alternative medicine in cardiovascular disease: part 1. Pharmacotherapy. 2010 Jan; 30(1):109.
Score: 0.002
-
Goodwin SD, Kane-Gill SL, Ng TM, Melroy JT, Hess MM, Tallian K, Trujillo TC, Vermeulen LC. Rewards and advancements for clinical pharmacists. Pharmacotherapy. 2010 Jan; 30(1):114.
Score: 0.002
-
Dobesh PP, Wittkowsky AK, Stacy Z, Dager WE, Trujillo TC, Gulseth MP, Nutescu E, Vondracek T. Key articles and guidelines in the treatment of venous thromboembolism. Pharmacotherapy. 2009 Nov; 29(11):1385.
Score: 0.002
-
Dobesh PP, Wittkowsky AK, Stacy Z, Dager WE, Haines ST, Lopez LM, Nutescu E, Phillips KW, Trujillo TC, Vondracek T. Key articles and guidelines for the prevention of venous thromboembolism. Pharmacotherapy. 2009 Apr; 29(4):410-58.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|